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Background: Increased pulmonary blood ﬂow (PBF) and shear stress
may provoke irreversible vascular remodeling. Visualization of the
micro-vasculature and the measurement of PBF velocity would provide
insights regarding the correlation between high PBF and vascular
remodeling. In this study, we aimed to establish a method for utilizing
synchrotron radiation pulmonary micro-angiography (SRPA) and
measure the PBF velocity in a high PBF rat model. Method: SRPA was
performed at the Photon Factory of the High Energy Accelerator
Research Organization (Tsukuba, Japan). Synchrotron radiation was
converted to monochromatic X-rays by 13° reﬂection on a silicon
crystal. High-sensitivity HARP (High-gain Avalanche Rushing Amor-
phous Photoconductor) detector camera with a ﬁber-optic plate
provided by the NHK Science and Technology Research Laboratories
and Hamamatsu Photonicswas used as an image receiver. As a high PBF
rat model, a ﬁstula between the abdominal aorta and IVC was created.
After 8 weeks, SRPAwas performed by transvenous infusion of contrast
medium. The dynamic changes of density at the pulmonary artery (PA)
were measured by a density measurement software (Gray-val; Library
Inc.Japan). The PBF velocity was calculated by the transit time of
contrast medium in PA. Result: The high spatial and density resolution
was achieved by SRPA. The minimum identiﬁed vascular diameter was
100 μm. The velocity of PA ﬂow in high PBF rats was signiﬁcantly
increased compared with control (2.3 ± 8.5 vs. 46.1 ± 4.3 mm/s).
Conclusion: These results demonstrate the effectiveness of SRPA for
visualizing the ﬂow distribution in micro-vasculature and measure PBF
velocity in a high PBF rat model. This newly developed technology may
help investigate themechanism of vascular remodeling associated with
high PBF and shear stress.
doi:10.1016/j.lfs.2014.01.019
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Despite the beneﬁcial roles, endotracheal suctioning is known to
accelerate lung injury during mechanical ventilation. More recently,
a growing body of evidence demonstrates discretely the difference of
open endotracheal suctioning (OES) and closed endotracheal suc-
tioning (CES) on the respiratory and hemodynamic parameters in acute
respiratory distress syndrome (ARDS). Endothelin-1 (ET-1), a mediator
of vascular inﬂammation, cell proliferation, and ﬁbrosis in addition to
being a potent vasoconstrictor has been potentially implicated in the
pathogenesis of ARDS. We investigated the effects of repeated OES vs.
CES during mechanical ventilation on circulatory and pulmonary levels
of ET-1 in ARDS. Brieﬂy, 18 Japanese White Rabbits were anesthetized
and intubated with a 3.5-mm endotracheal tube. Normal saline was
instilled into the lung andwashedmildly. After instillation, rabbitswere
ventilated at a deﬁnite setting; OES and CES duration was for 6 h and
performed every 30 min. At circulatory level, either OES or CES did not
alter plasma ET-1 level compared to the ET-1 level in ARDS before the
initiation of endotracheal suctioning (OES 4.7 ± 1.3 CES 4.8 ± 1.5,
p = .839). In contrast, pulmonary ET-1 level was signiﬁcantly higher in
CS group compared to the the OES group after 6 h of repeated
suctioning in lavage-induced ARDS (OES 27.2 ± 2.2 CES 29.7 ± 3.3,
p = .05). This change in pulmonary ET-1 level could maintain a parallel
relation with Pa02 level. The current observation for the ﬁrst time
reported the involvement of vasoactive peptide like ET-1 underlying
the pulmonary changes of closed suctioning during mechanical
ventilation in a lavage induced ARDS model.
doi:10.1016/j.lfs.2014.01.020
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Renal hemodynamics have important effects on blood pressure. Renal
arteries are highly sensitive to endothelin-1 (ET-1)-induced contractions,
which partly depend on NADPH oxidase (Nox)-mediated superoxide
generation. Aging is associated with increased superoxide production,
but whether this affects Nox-mediated vascular reactivity to ET-1 is
unknown. We studied the effect of aging on Nox-mediated contractions
to ET-1 (0.1 nmol/L-100 nmol/L) in isolated rings of renal arteries and
aortas from young and old C57BL6 mice (4 and 24 months of age).
Responses were obtained in the presence and absence of the Nox-
selective inhibitor gp91ds-tat (3 μmol/L) and calculated relative to
KCl (60 mmol/L)-induced contractions. The nitric oxide synthase inhib-
itor l-NAME (300 μmol/L) was used throughout the study to exclude
differential effects of nitric oxide bioavailability between vascular beds.
When compared to the aorta, maximal contractions to ET-1 in renal
arteries were 6-fold greater in young (102 ± 4% vs. 18 ± 4%, P b 0.01)
and 23-fold greater in old animals (92 ± 8% vs. 4 ± 1%, P b 0.01). Aging
did not affect ET-1-induced contractions in renal arteries, which were
inhibited by gp91ds-tat in both young and old animals (2-fold, P b 0.01).
In the aorta of young animals, contractions to ET-1 were equally reduced
by Nox inhibition and by vascular aging (4-fold, P b 0.05). In old aortas,
Nox inhibition had no further effect on responses to ET-1. In conclusion,
aging reduces contractions to ET-1 in the aorta by abolishing the
contribution of Nox. In contrast, the renal artery appears to be resistant
to aging-induced changes of Nox-dependent responses to ET-1. These
ﬁndings indicate a speciﬁc, localized role of Nox in functional vascular
aging that determines ET-1-dependent regulation of arterial tone.
doi:10.1016/j.lfs.2014.01.021
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Inadequate collateral formation in the heart in diabetic (DM) animals
and patients was considered to be partly caused by a decrease in
vascular endothelial growth factor (VEGF), the key angiogenic factor.
The present study was designed to investigate the therapeutic
implication to improve the defect in VEGF signaling in DM hearts by
ET antagonists. We investigated whether ET-A/B dual receptor antago-
nist (SB209670, 1 mg/kg/day) and ET-A receptor antagonist (TA-0201,
1 mg/kg/day) would reverse the downregulated VEGF signaling in early
streptozotocin (STZ)-induced diabetic hearts with no obvious cardiac
dysfunction in echocardiography. Male Sprague–Dawley rats were
administered citrate saline (vehicle) or STZ (65 mg/kg IP). One week
after the injection, animals were separated into those receiving
SB209670, TA-0201 or vehicle by osmotic mini pump for 2 weeks.
Cardiac ET-1 level was signiﬁcantly increased in DM than in non-DM
rats and SB209670 treatment greatly reversed the higher ET-1 levels in
DM heart than those by the TA-0201 treatment. VEGF level in DM
heart was signiﬁcantly decreased than in non-DM rats, SB209670 and
TA-0201 treatments completely prevented this VEGF downregulation in
DM hearts. The dual ET-A/B receptor blocker was more effective in
reversing the alterations in phosphorylated Akt and eNOS, the two
important downstreams of VEGF angiogenic signaling, in DM heart than
the ETA-receptor antagonist. In conclusion, ET antagonism is effective in
preventing the downregulation of VEGF in diabetic heart, and the dual
ET-A/B receptor antagonist and the selective ETA receptor antagonist
were effective in ameliorating the decreased VEGF signaling and
inadequate coronary collateral development in diabetic hearts.
doi:10.1016/j.lfs.2014.01.022
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Background: Endothelin-1 (ET-1) is implicated in the development
and progression of chronic kidney disease (CKD). It has also been linked
to increased cardiovascular risk in patients with CKD. Here we
evaluated plasma levels of endothelin-like domain peptide (ELDP;
preproET-1[93–166]) and CT-proET-1 (preproET-1[169–212]) in pa-
tients with proteinuric CKD after treatmentwith sitaxentan. Changes in
proET-1 peptides were compared with various parameters of cardio-
vascular and renal function. Methods and results: Twenty-seven
patients with proteinuric CKD receiving recommended renoprotective
treatment were randomised to 6 weeks of placebo, sitaxentan (100 mg
once daily), and nifedipine long-acting (30 mg once daily), in a double-
blind, three-way crossover study design. Renal and cardiovascular
function, and plasma biomarkers were measured at baseline, week 3,
and week 6 of each treatment period. ELDP and CT-proET-1 were
measured by speciﬁc sandwich ELISAs. Sitaxentan treatment resulted in
signiﬁcant increases in ELDP and CT-proET-1 at both 3 and 6 weeks
compared to baseline (mean increases % ± sem at 3 and 6 weeks:
ELDP +17.5 ± 3.2, +15.0 ± 3.5; CT-proET-1 + 12.9 ± 2.0, +14.4
± 2.6; p b 0.001 for all values). Placebo and nifedipine had no effect
on plasma ELDP and CT-proET-1. After 6 weeks sitaxentan plasma ELDP
and CT-proET-1 were negatively correlated with 24 h urinary Na+
excretion (p= 0.015, r2 = 0.2149; p = 0.013, r2 = 0.2227, respec-
tively). Conclusions: Increases in proET-1 biomarkers after sitaxentan
indicate that ETA antagonists block a negative feedback effect of ET-1 on
EDN1 gene expression that is mediated via ETA receptors. The inverse
relationship between plasma proET-1 biomarkers and urinary Na+
excretion after sitaxentan requires further investigation.
doi:10.1016/j.lfs.2014.01.023
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Aging is a main risk factor for carotid artery disease and stroke.
The constrictor peptides endothelin-1 and angiotensin II are
important modiﬁers of age-induced vascular diseases, partly through
altered activity of NADPH oxidase (Nox)-derived superoxide and
constrictor prostanoids. Whether aging affects Nox- or prostanoid-
mediated constrictor responses to endothelin-1 or angiotensin II in
carotid arteries is unknown. We studied contractions to endothelin-1
(0.1–100 nmol/L) and angiotensin II (100 nmol/L) in isolated com-
mon carotid artery rings from young and old C57BL6 mice (4 and
24 months of age). The nitric oxide synthase inhibitor l-NAME
(300 μmol/L) was used throughout the study to exclude endothelin
ETB receptor- or angiotensin AT2 receptor-mediatednitric oxide release
during contractions, which are given relative to KCl (60 mmol/L)-
induced responses. Some arteries were additionally incubated with the
Nox- speciﬁc inhibitor gp91ds-tat (3 μmol/L) or the thromboxane-
prostanoid receptor antagonist SQ 29′548 (1 μmol/L) for 30 min. Aging
markedly reducedmaximal responses (Emax) and the sensitivity (pD2)
to endothelin-1 (Emax 8.9 ± 1.8% vs. 26.2 ± 3.8%, 3-fold, P b 0.001;
pD28.02 ± 0.07 vs. 8.54 ± 0.02, P b 0.01). Inhibition of Nox activity
blunted endothelin-1-induced contractions by 42% and 63% in young
and old animals, respectively (P b 0.05), while the thromboxane-
prostanoid receptor antagonist had no effect in either group. Contrac-
tions to angiotensin II were weak in young and old animals (3.6 ± 0.4%
vs. 3.1 ± 0.2%, P = n.s.) and unaffected by gp91ds-tat or SQ 29′548. In
summary, aging selectively impairs contractions to endothelin-1 in
carotid arteries, which depend on Nox activity, but not on constrictor
prostanoids. Endothelin-1 but not angiotensin II seems to be involved in
functional aging of carotid arteries.
doi:10.1016/j.lfs.2014.01.024
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